<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Recash test site | Stampe Koefoed | Activity</title>
	<link>https://recash.wpsoul.net/members/chessweasel70/activity/</link>
	<atom:link href="https://recash.wpsoul.net/members/chessweasel70/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Stampe Koefoed.</description>
	<lastBuildDate>Tue, 19 May 2026 20:03:20 +0000</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">4d50ef4e41cb102ecbce35d8744f51da</guid>
				<title>Stampe Koefoed posted an update: Immune modulating therapies are associated with an increased [&#133;]</title>
				<link>https://recash.wpsoul.net/activity/p/55267/</link>
				<pubDate>Wed, 11 Dec 2024 22:09:36 +0000</pubDate>

									<content:encoded><![CDATA[<p>Immune modulating therapies are associated with an increased risk of infections and malignancies. This is of particular concern in elderly inflammatory bowel disease patients. This study aims to compare the safety and efficacy of vedolizumab between young and elderly inflammatory bowel disease patients.</p>
<p> A binational, multicentre,&hellip;<span class="activity-read-more" id="activity-read-more-55267"><a href="https://recash.wpsoul.net/activity/p/55267/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">c1dfbe3e27cec15ab298c9ca356f8300</guid>
				<title>Stampe Koefoed became a registered member</title>
				<link>https://recash.wpsoul.net/activity/p/54966/</link>
				<pubDate>Wed, 11 Dec 2024 21:49:44 +0000</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>